Dedicated to improving reproductive medicine. Nora is committed to the scientific development of therapeutics to address unmet clinical needs in reproductive medicine.


NT100 mimics the biological activity of a naturally occurring protein in the female reproductive tract to optimize maternal-fetal tolerance.

Learn more

News & Events

Nora Therapeutics Presents Phase 1 Data on NT100 at the European Society of Human Reproduction and Embryology Annual Meeting
(download here)

Learn more

Clinical Trials

Nora has initiated two Phase 2 clinical trials of its lead drug candidate, NT100, Thrive-IVF and RESPONSE.

Learn more